Continuation of d10: product id dvea3e4 (evx600791s); product type: 0235-icd; implant date (b)(6) 2024.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
It was reported that extravascular implantable cardioverter defibrillator (ev-icd) detected an episode of supra ventricular tachycar dia (svt) but the episode was suspected to be ventricular tachycardia (vt), delaying therapy.Additionally, the extravascular (ev) lead exhibited undersensing possibly delaying detection and therapy.An episode of oversensing with noise was observed.The device and lead remain in use. no further patient complications have been reported as a result of this event.
|